The Federal Reserve is scheduled to wrap up its two-day meeting on Wednesday afternoon, when it will announce its latest policy decisions. While experts do not anticipate a significant shift in the central bank’s posture, many are looking for signs on how the Fed is planning for potentially high inflation in the near future. Cornell experts, Sarah Wolfolds and Shawn Mankind, weigh in on the Fed's likely posture.
Susanne Bruyère is co-principal investigator for a National Science Foundation-funded team that is developing artificial intelligence technology to improve employment outcomes for people with autism spectrum disorder.
The powerful new telescope being built for a high-elevation site in Chile by a consortium of U.S., German and Canadian academic institutions, led by Cornell, has a new name: the Fred Young Submillimeter Telescope.
A new app co-developed by Cornell researchers is expected to streamline information-sharing, during the COVID-19 pandemic and beyond, for farmers in Bangladesh growing genetically engineered eggplant.
Fall 2020 marks the second year of the College of Agriculture and Life Sciences peer-mentoring program, developed to support incoming first-generation students and decrease racial disparities in academic achievement.
Researchers successfully engineered E. coli bacteria to produce O-linked glycoproteins – research that will illuminate the complex process of glycosylation and the role that protein-linked glycans play in health and disease.
Alexandra Blackman, assistant professor of government at Cornell University, comments on the Middle East deal signing Trump will be presiding on Tuesday.
Jaron Porciello in the Department of Global Development is exploring barriers to the widespread adoption of digital agriculture tools through a grant from USAID and the Bill & Melinda Gates Foundation.
As scientists prepare to study Martian soil for signs of life, a new worry emerges. Acidic fluids once on Mars’ surface may have destroyed biological evidence hidden within the planet’s iron-rich clays.
Ascribe Bioscience, a Cornell-based startup and UNY I-Corps alumni, has won a $750,000 National Science Foundation Small Business Innovation Research Phase II award.
